Oxysterols, cholesterol homeostasis, and Alzheimer disease.
about
Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrierApolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy24S-hydroxycholesterol effects on lipid metabolism genes are modeled in traumatic brain injuryNPC1/NPC2 function as a tag team duo to mobilize cholesterolOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseEBI2 regulates intracellular signaling and migration in human astrocyteApolipoprotein E and Alzheimer disease: risk, mechanisms and therapySulphatation does not appear to be a protective mechanism to prevent oxysterol accumulation in humans and miceLoading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterolsCholesterol-modifying strategies for Alzheimer's disease.Independent component analysis of Alzheimer's DNA microarray gene expression dataBlood-based biomarkers of Alzheimer's disease: challenging but feasibleHFE gene variants, iron, and lipids: a novel connection in Alzheimer's diseaseA second class of nuclear receptors for oxysterols: Regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol)Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampusLeptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slicesThe vascular contribution to Alzheimer's disease.Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profilesLong-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action.Theobromine-Induced Changes in A1 Purinergic Receptor Gene Expression and Distribution in a Rat Brain Alzheimer's Disease Model.Quantitative detection of free 24S-hydroxycholesterol, and 27-hydroxycholesterol from human serumDifferential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse eventsCholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disordersDifferential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy.Free radical oxidation of cholesterol and its precursors: Implications in cholesterol biosynthesis disorders.Induction of mitochondrial changes associated with oxidative stress on very long chain fatty acids (C22:0, C24:0, or C26:0)-treated human neuronal cells (SK-NB-E).Heme oxygenase effect on mesenchymal stem cells action on experimental Alzheimer's disease.Liver X receptor beta (LXRbeta): a link between beta-sitosterol and amyotrophic lateral sclerosis-Parkinson's dementiaApolipoprotein E and cholesterol in aging and disease in the brainDocosahexaenoic acid and the aging brain.Apolipoprotein E highly correlates with AbetaPP- and tau-related markers in human cerebrospinal fluid.Medical bioremediation of age-related diseases.Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1.The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice.Heme oxygenase-1 in Alzheimer disease: a tribute to Moussa Youdim.Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance.Cholesterol and Alzheimer's disease: a still poorly understood correlation.Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets.Dual effect of docosahexaenoic acid (attenuation or amplification) on C22:0-, C24:0-, and C26:0-induced mitochondrial dysfunctions and oxidative stress on human neuronal SK-N-BE cells.The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.
P2860
Q24316276-198FE151-062C-4396-A793-8F2FAE500774Q24604376-9E8FD1E9-4F3A-4623-AE6A-F5CB3AA06364Q24644336-A8589989-2D03-4345-BFDC-92982D5FB710Q24656276-226AAD4B-F35D-4F93-A805-47CFADDC9722Q27023315-BD05AEC7-1515-4120-B90E-F7DB198E9D58Q28116376-602B1089-3B9C-4A18-B031-3C0694D42091Q28282855-B13D636C-1C2A-4D08-8D13-76E7023CDC09Q28534492-7CC35668-816F-4158-B7FB-58DD0613AD5EQ28538558-9540DB4D-5FA1-4402-AE37-CC07D4EFC765Q33347051-8532BAC7-C8D0-4990-A7B5-3CB7A2C3605BQ33403405-7F670A2D-FEC0-4560-95C2-94CB9D60CEECQ33824444-E2F9CEE2-B407-42B5-9759-D8708B4762C1Q33861622-095CCE61-E5DC-47E5-9F6D-4F18C254E01EQ33915348-AB11D14E-268F-40B7-A006-156386B6B1A3Q34064442-6CDB6003-0D10-4380-B3BF-65466DEF6BDEQ34075070-6C3CC52A-AD38-4D87-BAF5-E4BB05328771Q34178526-ECB2F3F5-03D6-41F8-8BBF-ADABEDECF662Q34185639-7B1F3D7E-2957-4EE0-8B63-5E9C4C5EBE78Q34556705-AF639284-4D6F-49DE-B4A7-59E0C76CE598Q34679485-F38E2C16-DE1E-4E82-8AFC-E9E5D55502ABQ35005035-67322F37-D58D-46BE-8F0F-D21570389C69Q35076628-F82F5112-B450-41F3-AFC0-B38B4FE9C22AQ35087574-2029160C-4246-4AC0-87D2-C522CBC399B2Q35551439-96D25F8B-5CFF-4D9A-8EB3-3BFFA55A883DQ35706860-0A5CD173-6B58-41E5-AD99-0DFDF5BE94ACQ36167749-FF37A5C6-0D9D-4AEF-AB9D-8692EACA5F93Q36330120-67A1E6BC-D366-4520-B71A-52BEBD5D4501Q36890913-B3760C69-AA3D-4E7B-AB6B-AB70AA42109FQ37009967-CD64D8CB-D321-43EF-BCFC-7DCE018CAF6AQ37152345-D3278A5B-9559-4F64-A9EF-063251711FB1Q37155515-F62088E1-89C5-4A93-9080-4E67A52F4C83Q37172423-0F6A1E55-C851-4ECE-A826-109A8537644CQ37405213-AF3BF919-FA8A-4D29-AA44-33EA19D1D903Q37709691-206DA80F-3B09-4C94-94B5-7C3170E633D0Q37766494-B3395F95-F370-45A5-81F3-626163897F59Q37842745-BB1E8002-B283-4F9C-8773-B6AADE5A17A4Q38057684-5B78D101-489A-4053-B9EF-65F0BEA7D6D2Q38162657-97D5F06C-7973-4CFB-8BE3-FBE30337A7A6Q38913019-F4290E88-C419-4E60-A15A-A5A9B58509C7Q39348762-C6AE759E-FCE0-4F5E-A942-0D7C138B74E0
P2860
Oxysterols, cholesterol homeostasis, and Alzheimer disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Oxysterols, cholesterol homeostasis, and Alzheimer disease.
@en
type
label
Oxysterols, cholesterol homeostasis, and Alzheimer disease.
@en
prefLabel
Oxysterols, cholesterol homeostasis, and Alzheimer disease.
@en
P2860
P1476
Oxysterols, cholesterol homeostasis, and Alzheimer disease.
@en
P2093
Hyman M Schipper
Jacob Vaya
P2860
P304
P356
10.1111/J.1471-4159.2007.04689.X
P407
P577
2007-06-15T00:00:00Z